|
Rx class and/or
(indication)
|
Pharmaceutical
agent
|
Person-year
equivalents*
|
Costs
($)
|
|
Rapid acting insulin analogues (diabetes)
(Liver disease) (Gaucher's disease) (Renal anaemia) Anti-thrombotic agents |
insulin lispro
ursodeoxycholic acid imiglucerase erythropoietin alpha dipyridamole |
0.0
141.5 0.0 0.0 7330.2 |
1
749078
392 633 1 021854 4 805 021 1 731 904 |
|
Statins (HMG CoA reductase inhibitors)
(dyslipidaemia)
|
atorvastatin
fluvastatin pravastatin simvastatin |
45
332.7
2031.2 105.3 25 515.9 |
26 646
422
534 660 54 671 8 636 649 |
|
Anti-hypotensive agents
(Paget’s disease) (Osteoporosis) Antibacterials (Hepatitis B) |
midodrine
alendronate alendronate azithromycin lamivudine |
75.7
152.4 2748.4 0.0 230.8 |
58
265
237 666 2 113 149 238 462 431 437 |
|
(HIV/AIDS)
|
efavirenz
nevirapine abacavir didanosine (ddI) lamivudine stavudine (d4T) zalcitabine (DDC) zidovudine indinavir nelfinavir ritonavir saquinavir |
63.2
82.3 23.4 61.7 114.0 147.0 0.3 14.4 134.5 71.3 17.3 13.9 |
386
535
321 014 130 744 266 793 436 818 877 887 2553 105 981 661 425 491 248 192 570 59 793 |
|
Newer anti-epilepsy agents
|
gabapentin
topiramate lamotrigine |
57.1
259.3 1747.5 |
136
755
576 215 3 997 582 |
|
Anti-parkinson agents
|
tolcapone
|
226.9
|
420
872
|
|
Atypical anti psychotics
|
clozapine
olanzapine quetiapine risperidone |
2688.3
3242.3 350.2 8841.5 |
7 290
761
11 217 692 641 335 11 716 673 |
|
Hormone antagonists (excess growth hormone)
Hormone antagonists (advanced breast cancer) |
octreotide
anastrozole letrozole |
0.3
112.8 224.5 |
1 665
064
324 414 628 695 |
|
Immunosuppressants
(Multiple sclerosis) Long acting beta-adrenoceptor agonists (asthma) |
cyclosporin
A
tacrolimus beta-interferon eformoterol |
1839.7
227.1 0.0 3815.2 |
7 605
868
2 399287 3 295 663 1 636249 |
|
(Glaucoma)
|
brimonidine
dorzolamide latanoprost |
0.0
0.0 0.0 |
452
648
336 598 1 942 437 |
|
Total
|
|
108
040.2
|
108
870 041
|
|
Total excluding
statins
|
|
35
055.0
|
72
997 639
|